Literature DB >> 12043985

Incidence of DVT following surgery of the foot and ankle.

Gregory Solis1, Terence Saxby.   

Abstract

A prospective study was undertaken to establish the incidence of deep vein thrombosis (DVT) in patients who had undergone surgery of the foot and ankle. All consecutive patients who underwent foot and ankle surgery in the senior author's practice had duplex ultrasound performed of the bilateral calves at the first postoperative visit. Of 201 patients, deep calf clots were found in seven patients (3.5%), but none of these showed progression on follow-up ultrasound or extension proximal to the calf. By the authors' criteria, none of the studied patients required treatment. The authors feel that the rate and progression of DVT after foot and ankle surgery is low and does not require routine prophylaxis. Factors associated with risk of DVT formation were postoperative immobilization, hindfoot surgery, tourniquet time and advancing age.

Entities:  

Mesh:

Year:  2002        PMID: 12043985     DOI: 10.1177/107110070202300507

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  16 in total

1.  Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.

Authors:  Abdullah Pandor; Daniel Horner; Sarah Davis; Steve Goodacre; John W Stevens; Mark Clowes; Beverley J Hunt; Tim Nokes; Jonathan Keenan; Kerstin de Wit
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

2.  Incidence of deep vein thrombosis and pulmonary embolism after Achilles tendon rupture.

Authors:  Arush Patel; Brent Ogawa; Timothy Charlton; David Thordarson
Journal:  Clin Orthop Relat Res       Date:  2011-11-02       Impact factor: 4.176

3.  Thrombembolic complications after total ankle replacement.

Authors:  Alexej Barg; Katharina Barg; Stefan W Schneider; Geert Pagenstert; Marcel Gloyer; Heath B Henninger; Victor Valderrabano
Journal:  Curr Rev Musculoskelet Med       Date:  2013-09-28

4.  Prevalence of Acute Deep Vein Thrombosis in Patients with Ankle and Foot Fractures Treated with Nonoperative Management-A Pilot Study.

Authors:  Edward Ho; Abdullah Omari
Journal:  Int J Angiol       Date:  2015-07-10

5.  Incidence and risk factors of preoperative deep venous thrombosis in closed tibial shaft fracture: a prospective cohort study.

Authors:  Jiangtao Ma; Jin Qin; Meishuang Shang; Yali Zhou; Yingze Zhang; Yanbin Zhu
Journal:  Arch Orthop Trauma Surg       Date:  2020-11-21       Impact factor: 3.067

Review 6.  [Thromboembolic complications following ankle prosthesis implantation].

Authors:  A Barg; S W Schneider; G Pagenstert; B Hintermann; V Valderrabano
Journal:  Orthopade       Date:  2013-11       Impact factor: 1.087

Review 7.  Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery.

Authors:  James D F Calder; Richard Freeman; Erica Domeij-Arverud; C Niek van Dijk; Paul W Ackermann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-03-18       Impact factor: 4.342

8.  Relationship between the inflammation/immune indexes and deep venous thrombosis (DVT) incidence rate following tibial plateau fractures.

Authors:  Dawei Liu; Yanbin Zhu; Wei Chen; Junyong Li; Kuo Zhao; Junzhe Zhang; Hongyu Meng; Yingze Zhang
Journal:  J Orthop Surg Res       Date:  2020-07-02       Impact factor: 2.359

9.  The incidence and risk factors of deep venous thrombosis in lower extremities following surgically treated femoral shaft fracture: a retrospective case-control study.

Authors:  Zhixin Ren; Yufei Yuan; Wei Qi; Yanbao Li; Pengcheng Wang
Journal:  J Orthop Surg Res       Date:  2021-07-09       Impact factor: 2.359

10.  Incidence of deep venous thrombosis (DVT) of the lower extremity in patients undergoing surgeries for ankle fractures.

Authors:  Luo Zixuan; Wei Chen; Yansen Li; Xiaomeng Wang; Weili Zhang; Yanbin Zhu; Fengqi Zhang
Journal:  J Orthop Surg Res       Date:  2020-07-31       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.